Trials in Progress

A researcher looks off the his left thinking.

Your Path Forward

Discover opportunities to participate in trials

Each stage of the clinical trial process depends on the participation and input of people like you. If you or someone you’re caring for may be appropriate for one of our clinical trials, talk to your doctor and care team about the eligibility criteria.

For more information on our therapeutic areas of research, visit our Pipeline page.

Trials in Progress

Select a category to get a closer look at our trials in progress.

Showing 5 results

Latest Clinical Trials

  • Pulmonary Arterial Hypertension (PAH)

    Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension

    Trial Status

    • Recruiting
    • Phase 3
    • Multiple US locations available

    Key Participation Criteria*

    • Diagnosis of PAH confirmed by right heart catheterization
    • 6-minute walking distance ≥150 and ≤450 meters
    • Must not have obstructive or restrictive lung disease

    * Additional study criteria may apply

    PALM-PAH

    See full study details

  • Ataxia Telangiectasia (AT)

    Longitudinal Study Comparing the Natural History of Ataxia Telangiectasia in Children to Healthy Comparators

    Trial Status

    • Recruiting
    • Observational, Ongoing
    • Multiple US locations available

    Key Participation Criteria*

    • Aged from 1 year (12 months) and 10 years (<11 years) old, inclusive
    • Diagnosis of classic AT: Group 1
    • No diagnosis of any form of AT: Group 2

    * Additional study criteria may apply

    INSPIRE AT

    See full study details

  • Amyotrophic Lateral Sclerosis (ALS)

    A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal (IT) Injection of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

    Trial Status

    • Recruiting
    • Phase 1
    • Multiple US locations available

    Key Participation Criteria*

    • Participant with symptomatic ALS as diagnosed by Gold Coast diagnostic criteria
    • Baseline ALSFRS-R ≥ 24
    • ALS disease duration ≤ 42 months

    * Additional study criteria may apply

    ARMOR

    See full study details

  • Duchenne Muscular Dystrophy (DMD)

    A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

    Trial Status

    • Recruiting
    • Phase 1
    • Multiple US locations available

    Key Participation Criteria*

    • Male, 2-4 years old
    • Definitive diagnosis of DMD
    • Ability to walk >10 meters unassisted

    * Additional study criteria may apply

    ASCEND

    See full study details

  • Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

    Trial Status

    • Recruiting
    • Phase 3
    • Multiple US locations available

    Key Participation Criteria*

    • Diagnosis of Pulmonary Hypertension WHO Group 3 associated with Interstitial Lung Disease
    • Pulmonary Hypertension confirmed by right heart catheterization
    • Must not have primary diagnosis of chronic obstructive pulmonary disease (COPD)

    * Additional study criteria may apply

    PALM-ILD

    See full study details